James Engelhart - Net Worth and Insider Trading
James Engelhart Net Worth
The estimated net worth of James Engelhart is at least $157,640 dollars as of 2024-11-05. James Engelhart is the CFO of Biohaven Pharmaceutical Holding Co Ltd and owns about 11,196 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $157,640. Details can be seen in James Engelhart's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Engelhart has not made any transactions after 2021-12-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Engelhart
James Engelhart Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Engelhart owns 1 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) .
Click here to see the complete history of James Engelhart’s form 4 insider trades.
Insider Ownership Summary of James Engelhart
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2021-12-10 | Chief Financial Officer |
James Engelhart Latest Holdings Summary
James Engelhart currently owns a total of 1 stock. James Engelhart owns 11,196 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of December 10, 2021, with a value of $157,640.
Latest Holdings of James Engelhart
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2021-12-10 | 11,196 | 14.08 | 157,640 |
Holding Weightings of James Engelhart
James Engelhart Form 4 Trading Tracker
According to the SEC Form 4 filings, James Engelhart has made a total of 2 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the sale of 35,000 shares on December 10, 2021, which brought James Engelhart around $4 Million.
Insider Trading History of James Engelhart
- 1
James Engelhart Trading Performance
GuruFocus tracks the stock performance after each of James Engelhart's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Engelhart is 9.74%. GuruFocus also compares James Engelhart's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Engelhart within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Engelhart's insider trading performs compared to the benchmark.
Performance of James Engelhart
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.67 | | | | | |
| Relative Return to S&P 500(%) | 4.22 | | | | | |
James Engelhart Ownership Network
Ownership Network List of James Engelhart
Ownership Network Relation of James Engelhart
James Engelhart Owned Company Details
What does Biohaven Pharmaceutical Holding Co Ltd do?
Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?
James Engelhart is the Chief Financial Officer of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include VP & Chief Accounting Officer George C. Clark , Chief Medical Officer Elyse Stock , and Officer Matthew Buten .
Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biohaven Pharmaceutical Holding Co Ltd Insider Transactions
James Engelhart Mailing Address
Above is the net worth, insider trading, and ownership report for James Engelhart. You might contact James Engelhart via mailing address: C/o Biohaven Pharmaceutical Holding Comp 234 Church Street New Haven Ct 06510.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
